trial · primary record
Infliximab
Depressive Disorder, Major
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2029-01-31 |
| Primary endpoint | Executive Function (TestMyBrain: Choice Reaction Time - Median Response Time on Correct Trials) |
| Registry ID | NCT06136546 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.448Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06136546
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.